CSIMarket
 
Puretech Health Plc  (PRTC)
Other Ticker:  
 

Puretech Health Plc

Business Description


Puretech Health Plc is a leading biopharmaceutical company that focuses on developing innovative medicines aimed at addressing unmet medical needs. The company was founded in 2002 and is headquartered in Boston, Massachusetts.

Puretech Health operates through its various subsidiaries, which include Akili Interactive, Alivio Therapeutics, and Karuna Therapeutics, among others. These subsidiaries focus on different therapeutic areas such as neuroscience, immunology, and oncology, respectively.

One of the key strengths of Puretech Health is its unique approach to developing therapies. The company identifies and validates clinical problems before creating and developing novel solutions. This approach allows Puretech Health to target diseases and conditions that have been overlooked or inadequately addressed by current treatments.

Puretech Health has a strong pipeline of product candidates at various stages of development. The company*s drug candidates are based on scientific discoveries made in academic and industrial research institutions worldwide. Puretech Health*s expertise lies in transforming these discoveries into commercially viable therapies through a rigorous development process.

The company*s flagship product candidate is an oral immunotherapy for peanut allergy called AR101. AR101 has received breakthrough therapy designation from the U.S. Food and Drug Administration (FDA) and has demonstrated promising results in clinical trials. Puretech Health is currently awaiting regulatory approval for the commercialization of AR101.

In addition to its drug development efforts, Puretech Health also focuses on digital health and medical devices. The company*s subsidiary, Akili Interactive, has developed a digital therapeutic for children with attention-deficit/hyperactivity disorder (ADHD). This novel therapy has shown significant improvements in cognitive function and is being reviewed by the FDA for approval.

Puretech Health has a collaborative approach to partnerships and has established strategic alliances with leading pharmaceutical and biotechnology companies. These collaborations help the company gain access to additional resources and expertise, accelerating the development and commercialization of its product candidates.

Financially, Puretech Health has a strong balance sheet, with a diverse and supportive investor base. The company has raised substantial capital through public offerings and private placements to support its research and development activities.

In summary, Puretech Health is a biopharmaceutical company with a unique approach to developing therapies for unmet medical needs. The company*s strong pipeline, strategic partnerships, and focus on digital health make it a key player in the healthcare industry. With its innovative products and dedication to improving patients* lives, Puretech Health is well-positioned for future growth and success.



View Company Supplier View Company Competition View Company Customers


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com